Tyr tyrosine
TLR expression in different cell typesThe epithelial layer provides the first line of defence against invading pathogens. As a consequence, many TLRs are expressed on epithelial cells of the intestinal, respiratory and urogenital tracts.Microbial detecting by TLRs expressed by these cells leads to production of cytokines, chemokines and antimicrobial peptides (Iwasaki and Medzhitov, 2004). Many types of PRRs are expressed by dendritic cells (DCs), including C-type lectins, mannose receptors and TLRs. Studies of DC subsets revealed that TLRs have distinct expression patterns and there are also distinct differences in expression and responsiveness of certain TLRs in freshly isolated DCs versus in vitro-derived DCs. Plasmacytoid DCs (pDCs) express TLR7 and TLR9, whereas myeloid DCs (mDCs) express TLR1-3, TLR5, TLR6 and TLR8. Human blood monocytes express TLR1, 2, 4 and 5. Only monocytes and in vitro-differentiated DCs express TLR4 and respond thus to LPS stimulation (Iwasaki and Medzhitov, 2004). TLRs are also expressed by liver cells. Hepatic pDCs also produce tumor necrosis factor (TNF) -α, interleukin (IL) -6 and IL-12 by TLR7 and TLR9 stimulation. In general, hepatic DCs are hyperresponsive to TLR ligands. Kupffer cells are the first cells to encounter gut-derived toxins including LPS, thus TLR4 signalling drives Kupffer cells to produce TNF-α, IL-6, -12, -18 and anti-inflammatory cytokine IL-10. IL-12 and IL-18 activate hepatic natural killer (NK) cells to increase the synthesis and release of antimicrobial IFN-γ. Kupffer cells also express TLR2, TLR3 and TLR9. Hepatocytes express a very low level of TLR2-5 and their responses are fairly weak in vivo. Hepatic stellate cells (HSCs) express TLR4 and TLR9, while TLR2-5 are expressed by biliary epithelial cells (Seki and Brenner, 2008).
TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C